TCL Archive FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug July 26, 2013
TCL Archive NCI to Establish Three Grants Programs Supporting Clinical Cancer Research February 18, 1994